Althea offers cGMP plasmid production, protein production, formulation and filling services. Plasmid DNA and protein production are offered using both Althea’s industry-leading manufacturing process as well as client developed processes. A range of options are available for formulation and filling services ranging from semi- automated to fully- automated processes for vials and syringes. Althea is focused on offering highly responsive customer service, flexible scheduling, and rapid turnaround times to meet the requirements of both early stage clinical programs and commercial programs alike.
Althea Technologies Completes New State-of-the-Art, Commercial-Scale, Biologics and Injectables Manufacturing Facility
Althea Technologies Appoints Dr. Shabbir Anik as Chief Executive Officer
Althea Technologies Receives Fast Growth Honors: Deloitte Technology Fast 50 and San Diego Busienss Journal Fast 100 Awards for the Fifth Consecutive Year
Althea Technologies Secures $12 M Credit Line to Continue Facility Growth and Expansion
Althea Technologies Appoints E.J. Brandreth to Vice President of Quality and Regulatory
Althea Technologies Signs Accord with Protein'Expert, SA to Expand Development and Manufacturing Services
Althea Technologies Celebrates Ten Years of Building Innovation with Charity Connection
Althea Diagnostics Board of Directors Appoints Industry Veteran CEO
Althea Technologies Announces the Spin-out of an Independent Company, Althea Diagnostics
Althea Technologies Chosen By Quintessence Biosciences to Produce Lead Protein Oncology Drug
Althea Technologies Receives Two Fast Growth Awards: Deloitte & Touche and San Diego Business Journal for the Fourth Consecutive Year
Althea Technologies Gains National Spotlight as Wall Street Journal Top Workplace Finalist
Althea Technologies Expands Collaboration with BiPar Sciences
Althea Technologies Names Karen Daniels as President of the Company's Bio-Services Division
Althea Technologies Contracted by GeoVax to Produce
a Phase 2 AIDS Vaccine
Althea Technologies’ Manufacturing Capacity
Grows Through New Facility Construction
Althea Technologies Repeats as One of the “Best
Places to Work” in San Diego
Althea Technologies Announces the Development
of a Diagnostic Capable of Differentiating Multiple Forms of Childhood
Cancer
Althea Technologies and Blueshift Biotechnologies
Combine Technologies for High Throughput, Gene Expression Screening
Althea Technologies Closes $23 Million Financing
Althea Technologies to Present at the Upcoming
BIOCOM Investors Conference in San Diego
Althea Technologies Selected by Deloitte & Touche as one of
San Diego’s Fastest Growing Technology Companies for the Third
Year
Althea Technologies Selected as One of the Best Places to Work in San Diego, California by Employers Group and San Diego Magazine
Althea Technologies Awarded Advanced Bioscience Laboratories Contract to Produce DNA-based HIV Vaccine for U.S. NIAID
Althea Technologies to Manufacture Altus Pharmaceutical's ALTU-238 Human Growth Hormone for Phase III Studies
Althea Technologies Contracted by Powdermed to Produce Innovative Plasmid DNA-based Influenza Vaccine
Entrepreneur's Hub: Magda Marquet and Francois
Ferre
Althea Technologies Receives The Corporate UCSD Athena Pinnacle Award
Althea Technologies Announces the Appointment of
Chris Duffy as VP of Operations and Roy Musil as VP of Quality and
Regulatory Affairs
Althea Technologies Appoints R. Gary Gilmore
as Chief Financial Officer and Promotes Rick Hancock to Chief Operating
Officer
Althea Technologies Announces cGMP Facilities
Expansion
Althea Introduces Time Saving Assay For
Predicting Carcinogenicity Using PCR-Based Gene Expression Profiling
Althea Launches GLP Clinical Gene Expression
Services Using Beckman Coulter’s GeXP Quantitative Multiplexed PCR
System
Althea Offers cGMP Lyophilization Services
Althea Selected by Deloitte & Touche as One of San Diego's 50 Fastest Growing Technology Companies
Althea Founders Receive Ernst & Young’s 2005 San Diego Entrepreneur Of The Year Award
Althea Awarded by the San Diego Regional Chamber of Commerce for Excellence in the Work Environment
Althea Presents Application of Gene Expression Technology for Cancer Diagnostics
Finalists named for San Diego Entrepreneur of the Year Awards
UCSD Athena Announces 2005 Pinnacle Awards Winners
Althea Selected by Lorantis for Recombinant Protein Manufacturing Project
Althea Awarded NCI Grant to Apply Innovative Technology in Compound Library Expression Screening
San Diego Union Tribune:
A new model for cancer research
Baxter Renews Co-Promotion Agreement with Althea for Manufacturing Services
San Diego Union Tribune: People to Watch
Penn Pharmaceutical Services Assists Althea
Technologies with Importation of Clinical Trial Supplies into Europe
Natural Selection and Althea Technologies in Strategic Alliance to Provide Gene Expression Biomarker Discovery
Althea Technologies Receives Local Business Awards from the San Diego Business Journal & Deloitte and Touche
Althea Awarded NCI Grant to Apply Innovative Technology in Diagnosis of Childhood Cancers
Expression Analysis and Althea Technologies in Strategic Alliance to Expedite Genomic Biomarker Identification and Application
Althea Selected by Deloitte & Touche as One of San Diego's Fastest Growing Technology Companies
Althea Awarded Innovative Toxicology Grant From NIH
Beckman Coulter Signs Agreement with Althea Technologies for Gene
Expression Technology
Althea Names Alan Moore as Executive Vice President and Chief Business Officer
Althea Announces Co-Promotion Agreement with Baxter for Manufacturing Services
Althea Announces Issuance of U.S. Patent for High-Throughput Gene Expression Analysis
Althea Awarded Technology Grant
Althea Receives Manufacturing Contract From National Institutes of Health
Althea Expands to New Headquarters
Althea Presents Multiplex PCR Data Related to Toxicogenomics
Althea's eXpress Profiling Technology Used in High-Throughput Multiplexed
Gene Expression Study
Althea Technologies Strengthens Its Management Team
Comerica Provides $1.6 Million Credit Facility to Althea Technologies
Althea Technologies
A leading provider of contract services to
the pharmaceutical and biotechnology industries
11040 Roselle Street | San Diego, CA 92121-1205
Toll-free 1-888-4ALTHEA
info@altheatech.com